Perspective Therapeutics Introduces "Pre-Targeting" Theranos

Signs a World-Wide Exclusive License with Stony Brook University for a Novel Platform that can Enhance Radionuclide TargetingReceives up to $2.4M ...

Related Keywords

United States , American , Jacobl Houghton , Michaelk Schultz , Thijs Spoor , Vilmaij Jallinoja , Jacob Houghton , Department Of Energy , Journal Of Nuclear Medicine , National Institutes Of Health , National Cancer Institute , Fastrack Small Business Innovation Research , Perspective Therapeutics Inc , Radiology At Stony Brook University , Stony Brook University , World Molecular Imaging Congress , Exchange Commission , World Wide Exclusive License , Novel Platform , Enhance Radionuclide , National Institutes , Chief Executive Officer , Chief Science Officer , Adamantane Host , Guest Pair , Xenograft Models , Stony Brook , Assistant Professor , Perspective Therapeutics , Transition Report , Quarterly Report ,